New KMY tablet tested in healthy people for safety
Knowledge-focused
Not yet recruiting
This early-stage study tests the safety and tolerability of KMY tablets in 120 healthy adults aged 18-45. Participants receive single or multiple doses, and some take the tablet with a high-fat meal to see how food affects the drug. The goal is to gather safety data and understan…
Phase: PHASE1 • Sponsor: Lei Yunshang Group • Aim: Knowledge-focused
Last updated May 01, 2026 16:01 UTC